LUNG CANCER RESEARCH
The granting of funds for research into the cure of lung cancer
Financial health, per its FY2024 accounts
The accounts state that unrestricted reserves decreased from £366,020 to £335,866 during the year, resulting in a net movement in funds of negative £30,154. The charity reported incoming resources of £67,744, primarily from donations, against total resources expended of £97,898. The trustees confirmed that accounting records were kept in accordance with the Charities Act and no matters requiring attention were identified by the independent examiner.
What the accounts disclose
“Legacies from estates Christine Bellamy 37,507”
Trustees
- Alastair Stephen Meeks BA Honschair
- Nicola Anne Wyborn
- Professor Michael Julian Seckl PhD
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £68k | £98k |
| 31/12/2023 | £9k | £115k |
Common questions
Is LUNG CANCER RESEARCH financially healthy?
Per its FY2024 accounts: The accounts state that unrestricted reserves decreased from £366,020 to £335,866 during the year, resulting in a net movement in funds of negative £30,154. The charity reported incoming resources of £67,744, primarily from donations, against total resources expended of £97,898. The trustees confirmed that accounting records were kept in accordance with the Charities Act and no matters requiring attention were identified by the independent examiner. Its FY2024 accounts were independently examined.